Literature DB >> 9114428

Detection of genetically diverse human immunodeficiency virus type 1 group M and O isolates by PCR.

R A Respess1, A Butcher, H Wang, T Chaowanachan, N Young, N Shaffer, T D Mastro, B Biryahwaho, R Downing, A Tanuri, M Schechter, R Pascu, L Zekeng, L Kaptué, L Gürtler, J Eberle, D Ellenberger, C Fridlund, M Rayfield, S Kwok.   

Abstract

A panel of 136 genetically diverse group M and 5 group O adult isolates from outside the United States and Europe were evaluated by PCR with the Roche AMPLICOR HIV-1 test, a modified version of the AMPLICOR HIV-1 test, and a new primer pair/probe system. Detection of some of these isolates was less efficient with the AMPLICOR HIV-1 test; however, the assay was significantly improved by reducing the sample input and lowering the annealing temperature. The new primer pair/probe set detected 140 of 141 isolates, including the 5 group O isolates that were not detected with either of the AMPLICOR HIV-1 test formats.

Entities:  

Mesh：

Year:  1997        PMID： 9114428      PMCID： PMC232750          DOI： 10.1128/jcm.35.5.1284-1286.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  19 in total

1.  HIV-1 group O virus identified for the first time in the United States.

Authors:  M A Rayfield; P Sullivan; C I Bandea; L Britvan; R A Otten; C P Pau; D Pieniazek; S Subbarao; P Simon; C A Schable; A C Wright; J Ward; G Schochetman
Journal:  Emerg Infect Dis       Date:  1996 Jul-Sep       Impact factor: 6.883

2.  DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells.

Authors:  C Y Ou; S Kwok; S W Mitchell; D H Mack; J J Sninsky; J W Krebs; P Feorino; D Warfield; G Schochetman
Journal:  Science       Date:  1988-01-15       Impact factor: 47.728

3.  HIV type 1 sequence subtype G transmission from mother to infant: failure of variant sequence species to amplify in the Roche Amplicor Test.

Authors:  C Arnold; K L Barlow; S Kaye; C Loveday; P Balfe; J P Clewley
Journal:  AIDS Res Hum Retroviruses       Date:  1995-08       Impact factor: 2.205

4.  Genetic diversity and HIV detection by polymerase chain reaction.

Authors:  I Loussert-Ajaka; D Descamps; F Simon; F Brun-Vézinet; M Ekwalanga; S Saragosti
Journal:  Lancet       Date:  1995-09-30       Impact factor: 79.321

5.  Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS.

Authors:  B H Hahn; G M Shaw; M E Taylor; R R Redfield; P D Markham; S Z Salahuddin; F Wong-Staal; R C Gallo; E S Parks; W P Parks
Journal:  Science       Date:  1986-06-20       Impact factor: 47.728

6.  Differences in cytopathogenicity and host cell range among infectious molecular clones of human immunodeficiency virus type 1 simultaneously isolated from an individual.

Authors:  K Sakai; S Dewhurst; X Y Ma; D J Volsky
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

7.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

8.  Genetic analysis of human immunodeficiency virus type 1 strains from patients in Cyprus: identification of a new subtype designated subtype I.

Authors:  L G Kostrikis; E Bagdades; Y Cao; L Zhang; D Dimitriou; D D Ho
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

9.  The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention.

Authors:  D J Hu; T J Dondero; M A Rayfield; J R George; G Schochetman; H W Jaffe; C C Luo; M L Kalish; B G Weniger; C P Pau; C A Schable; J W Curran
Journal:  JAMA       Date:  1996-01-17       Impact factor: 56.272

10.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728
View more
  5 in total

1.  Quantitation of human immunodeficiency virus type 1 group O load in plasma by measuring reverse transcriptase activity.

Authors:  J G García Lerma; V Soriano; A Mas; M E Quiñones-Mateu; E J Arts; W Heneine
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Performance of a multiplex qualitative PCR LCx assay for detection of human immunodeficiency virus type 1 (HIV-1) group M subtypes, group O, and HIV-2.

Authors:  K Abravaya; C Esping; R Hoenle; J Gorzowski; R Perry; P Kroeger; J Robinson; R Flanders
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Detection of phylogenetically diverse human immunodeficiency virus type 1 groups M and O from plasma by using highly sensitive and specific generic primers.

Authors:  C Yang; D Pieniazek; S M Owen; C Fridlund; J Nkengasong; T D Mastro; M A Rayfield; R Downing; B Biryawaho; A Tanuri; L Zekeng; G van der Groen; F Gao; R B Lal
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

4.  Design and evaluation of a human immunodeficiency virus type 1 RNA assay using nucleic acid sequence-based amplification technology able to quantify both group M and O viruses by using the long terminal repeat as target.

Authors:  M P de Baar; A M van der Schoot; J Goudsmit; F Jacobs; R Ehren; K H van der Horn; P Oudshoorn; F de Wolf; A de Ronde
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

5.  Evaluation of the prototype Roche DNA amplification kit incorporating the new SSK145 and SKCC1B primers in detection of human immunodeficiency virus type 1 DNA in Zimbabwe.

Authors:  L S Zijenah; J Humphrey; K Nathoo; L Malaba; P Zvandasara; A Mahomva; P Iliff; M T Mbizvo
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.